While coping ahead is a helpful strategy for managing worry, dreading ahead causes a host of problems. Individuals can ...
Detailed price information for Incannex Healthcare Inc ADR (IXHL-Q) from The Globe and Mail including charting and trades.
Incannex Healthcare Inc. (Nasdaq: IXHL) , a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today reported that it holds approximately $75 ...
Detailed price information for Incannex Healthcare Inc ADR (IXHL-Q) from The Globe and Mail including charting and trades.
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today announced that it has regained compliance with ...
The "worry window" technique involves setting aside 15 to 30 minutes each day to, well, worry. Health reporter Kim Schewitz ...
Medicinal cannabis might be increasingly available in many parts of the world, but a new review suggests it has no demonstrable benefit for depression or anxiety disorders. No proven benefit was ...
This clinical-stage biopharma targets neurological and psychiatric disorders with a pipeline of novel therapeutics advancing through trials.
Behavioral and anxiety disorders were the most prevalent psychiatric diagnoses among US children during their first year of institutionalized care.
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact ...
ScienceAlert on MSN
Large Medical Cannabis Review Finds Scarce Evidence It Treats Mental Health Disorders
(Anastassiya Bezhekeneva/Getty Images) A large umbrella review has found no strong evidence to date that medicinal cannabis ...
Georgia’s Largest Public HBCU Joins National Cohort to Expand Campus Behavioral Health, Mental Health Services, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results